EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC

Clinical trial NCT02886195 · UNKNOWN

Trial details

NCT number: NCT02886195
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

EGFR Gene Mutation

Start date: 2016-07-01
Primary completion: 2019-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.